NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Agenus Inc. Share Price Chart

O H L

Agenus Inc. Performance Overview

Days Range
$7.36Low
$7.77High

Markets Today

Previous Close$7.22
Open$7.69
Volume382,777
Day's Range$7.36 - $7.77
52W Range$2.71 - $8.85
Market Cap$325.62 M

Historical Performance

1M Returns-4.12
3M Returns+140.67
6M Returns+92.02
1Y Returns+58.68
5Y Returns-93.81
10Y Returns-94.67

Agenus Inc. Fundamentals

Market Cap$325.62 M
Dividend yield0.00
PE Ratio2.73
PEG RatioN/A
Revenue$114.20 M
ROE TTMN/A
EPS TTM$2.64
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-10.17 M
Profit Margin-0.09
Market Cap$325.62 M
Dividend yield0.00
PE Ratio2.73
PEG RatioN/A
Revenue$114.20 M
ROE TTMN/A
EPS TTM$2.64
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-10.17 M
Profit Margin-0.09

Agenus Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$24.07 M$25.69 M$30.23 M$34.20 M$33.74 M$34.52 M
Gross Profit +$23.93 M$25.45 M$29.59 M$34.20 M$33.74 M$34.52 M
Operating Income -$13.31 M-$16.71 M-$4.54 M$14.40 M$15.05 M$11.29 M
EBITDA -$10.11 M-$13.54 M-$1.51 M$14.99 M$15.64 M$11.81 M
Interest Expense $0-$13.29 M$0$0$0-$15.24 M
Depreciation $3.20 M$3.17 M$3.03 M$597.00 K$583.00 K$517.00 K
Income Before Tax -$26.37 M-$30.01 M$63.91 M-$10.61 M$39.21 M-$567.00 K
Income Tax Expense $0$0$0$0$0$0
Net Income +-$26.37 M-$30.01 M$63.91 M-$10.61 M$39.21 M-$567.00 K
Net Profit Margin -109.57%-116.82%211.38%-31.03%116.21%-1.64%

Agenus Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $266.00 K$300.00 K$329.00 K$353.00 K$385.00 K$427.00 K
Reserve & Surplus -$2.21 B-$2.24 B-$2.17 B-$2.18 B-$2.14 B-$2.14 B
Non-Current Liabilities $314.30 M$286.97 M$227.63 M$181.17 M$165.20 M$146.72 M
Current Liabilities $208.30 M$234.56 M$232.57 M$272.75 M$249.24 M$231.82 M
Total Liabilities $522.60 M$521.53 M$514.76 M$504.66 M$414.44 M$378.54 M
Fixed Assets $120.32 M$115.93 M$19.11 M$18.51 M$17.91 M$17.20 M
Current Assets $23.14 M$13.34 M$133.95 M$133.44 M$95.28 M$78.81 M
Total Assets $200.20 M$185.22 M$233.89 M$226.80 M$186.46 M$172.69 M

Agenus Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$26.37 M-$30.01 M$63.91 M-$10.61 M$39.21 M-$567.00 K
Operating Cash Flow -$25.62 M-$20.22 M-$14.74 M-$16.62 M-$35.95 M-$31.20 M
Investing Cash Flow $57.00 K$281.00 K$76.00 K$780.00 K$68.95 M$267.00 K
Financing Cash Flow $3.59 M$10.94 M$6.68 M$15.37 M-$993.00 K$14.68 M
Change in Cash -$21.95 M-$8.95 M-$8.00 M-$460.00 K$32.00 M-$16.26 M

Agenus Inc. Return Calculator

The Agenus Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$629
Invested Amount$10,000
Est. Returns$-9,371
Invest in USA Stock Today

About Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

FAQs

Agenus Inc. (AGEN) share price as of September 18, 2026 is $7.33. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Agenus Inc. (AGEN) Share by opening an international trading account with Angel One.
Purchasing Agenus Inc. (AGEN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Agenus Inc. (AGEN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Agenus Inc. (AGEN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Agenus Inc. on September 18, 2026, is $325.62 M.
Agenus Inc. operates in the null sector, specifically in the null industry.
In order to invest in Agenus Inc. (AGEN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91